Patient-reported outcomes of neoadjuvant apalutamide (ARN-509) and radical prostatectomy in treatment of intermediate to high risk prostate cancer (NEAR) trial – a phase II trial

Bibliographic Details
Main Authors: X.Y. Yang, E.J. Aslim, T.W. Chong, J.S.P. Yuen, K.J. Tay, H.S.S. Ho, L.S. Lee
Format: Article
Language:English
Published: Elsevier 2020-07-01
Series:European Urology Open Science
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168320337010